• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
G2 Intelligence Has Some Exciting News to Share!

G2 Intelligence Has Some Exciting News to Share!

by G2 Intelligence Staff | Sep 22, 2023 | News, Open Content

G2 Intelligence to change subscription model to better serve the laboratory industry with more analysis and insight

Is a Newly Proposed Rule Meant to Stop Healthcare Consolidation?

Is a Newly Proposed Rule Meant to Stop Healthcare Consolidation?

by Glenn S. Demby | Sep 21, 2023 | News, Open Content

The new rule put forth by the FTC and DOJ would make mergers and acquisitions much more difficult to achieve.

Quest Expands into MRD Liquid Biopsy with Haystack Oncology Buy

Quest Expands into MRD Liquid Biopsy with Haystack Oncology Buy

by Glenn S. Demby | May 10, 2023 | News, Open Content

The acquisition of the Johns Hopkins spin out and its liquid biopsy ctDNA test will significantly strengthen Quest’s oncology offerings.

Lab Business: It’s Back to Basics for LabCorp & Enzo Biochem

Lab Business: It’s Back to Basics for LabCorp & Enzo Biochem

by Glenn S. Demby | Mar 20, 2023 | News, Open Content

Enzo recently announced that it is selling its lab division to LabCorp for $146 million in cash.

Clinical Lab Services Market to Be Worth More than $125.6 Billion by 2030

Clinical Lab Services Market to Be Worth More than $125.6 Billion by 2030

by Rachel Muenz | Mar 15, 2023 | News, Open Content

A recently released report estimates that the US market will grow at a CAGR of 4.2 percent over the next seven years.

« Older Entries

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com